We are live on ! Find out more
MRGE

MERGE HEALTHCARE INC COM STK (WI)
MRGE

Delisted

MRGE was delisted on the 13th of October, 2015.

124 hedge funds and large institutions have $187M invested in MERGE HEALTHCARE INC COM STK (WI) in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

589% more call options, than puts

Call options by funds: $131K | Put options by funds: $19K

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

9% more capital invested

Capital invested by funds: $172M → $187M (+$15.2M)

7% more funds holding

Funds holding: 116124 (+8)

15% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 47

Holders
124
Holders Change
+8
Holders Change %
+6.9%
% of All Funds
3.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
40
Reduced
47
Closed
15
Calls
$131K
Puts
$19K
Net Calls
+$112K
Net Calls Change
+$83K
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$15.9M -$6.32M -1,320,100 -29%
KCM
2
Kennedy Capital Management
Missouri
$15.5M +$1.54M +322,160 +11%
Vanguard Group
3
Vanguard Group
Pennsylvania
$14.6M +$1.85M +385,604 +14%
BIT
4
BlackRock Institutional Trust
California
$10.9M -$248K -51,869 -2%
BFA
5
BlackRock Fund Advisors
California
$8.79M -$746K -155,948 -8%
NI
6
Numeric Investors
Massachusetts
$8.24M -$93.3K -19,500 -1%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$7.59M +$1.97M +411,382 +35%
JP Morgan Chase
8
JP Morgan Chase
New York
$7.21M -$12.7K -2,650 -0.2%
Renaissance Technologies
9
Renaissance Technologies
New York
$6.87M +$2.04M +425,600 +42%
State Street
10
State Street
Massachusetts
$5.47M -$528K -110,245 -9%
SCA
11
STALEY CAPITAL ADVISERS
Pennsylvania
$5.14M +$593K +123,883 +13%
TCM
12
Tieton Capital Management
Washington
$5.05M -$1.14M -237,717 -18%
MCM
13
McKinley Capital Management
Alaska
$4.76M -$7.68K -1,604 -0.2%
MC
14
Moors & Cabot
Massachusetts
$4.05M +$144K +30,000 +4%
Northern Trust
15
Northern Trust
Illinois
$4.04M -$93.4K -19,526 -2%
RFC
16
Russell Frank Company
Washington
$3.44M +$3.05M +636,259 +780%
OAM
17
Oxford Asset Management
United Kingdom
$2.83M -$350K -73,207 -11%
SFM
18
Systematic Financial Management
New Jersey
$2.49M -$109K -22,818 -4%
GC
19
Globeflex Capital
California
$2.41M -$4.34K -907 -0.2%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$2.28M +$183K +38,310 +9%
TCIM
21
TIAA CREF Investment Management
New York
$2.23M +$155K +32,329 +7%
Wells Fargo
22
Wells Fargo
California
$2.19M +$40.9K +8,537 +2%
Invesco
23
Invesco
Georgia
$2.16M +$1.87M +389,700 +638%
SGAM
24
Smith Group Asset Management
Texas
$2.09M +$46.7K +9,750 +2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.92M +$387K +80,862 +25%

MRGE Hedge Fund Activity: Q2 2015 in Review

124 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in MERGE HEALTHCARE INC COM STK (WI) (MRGE) for Q2 2015, worth a combined $187M — up 8.9% from $172M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MRGE positions and 15 closed out — a net gain of 8 holders — while 40 added to existing stakes and 47 trimmed.

The largest buyer was Russell Frank Company, adding an estimated $3.05M. The largest seller was OrbiMed, cutting an estimated $6.32M.

  • 124 institutional investors held MERGE HEALTHCARE INC COM STK (WI) (MRGE) as of Q2 2015, up from 116 in Q1 2015.
  • Funds reported $187M of MERGE HEALTHCARE INC COM STK (WI) stock for Q2 2015, up 8.9% quarter-over-quarter.
  • 23 funds opened new MERGE HEALTHCARE INC COM STK (WI) positions in Q2 2015 and 15 closed out, a net change of +8 holders.
  • The largest MERGE HEALTHCARE INC COM STK (WI) buyer in Q2 2015 was Russell Frank Company, an estimated $3.05M added.
  • The largest MERGE HEALTHCARE INC COM STK (WI) seller in Q2 2015 was OrbiMed, an estimated $6.32M sold.

Based on aggregated 13F filings for Q2 2015.